Use of plasma ctDNA as a potential biomarker for longitudinal monitoring of a patient with metastatic high-risk upper tract urothelial carcinoma receiving pembrolizumab and personalized neoepitope-derived multipeptide vaccinations: a case report.
Journal For Immunotherapy Of Cancer
Blumendeller, Carolin C; Boehme, Julius J; Frick, Maximilian M; Schulze, Martin M; Rinckleb, Antje A; Kyzirakos, Christina C; Kayser, Simone S; Kopp, Maria M; Kelkenberg, Sabine S; Pieper, Natalia N; Bartsch, Oliver O; Hadaschick, Dirk D; Battke, Florian F; Stenzl, Arnulf A; Biskup, Saskia S